Open-architecture xMAP® Technology allows simultaneous detection of bacterial, viral, and toxin agents in a highly flexible, multiplexed architecture capable of protein and nucleic acid assay formats. The xMAP suspension array technology enables multiplex identification of up to 500 analytes in a single reaction using small sample volumes. The microsphere technology platform offers easy expansion capability, wherein additional bead sets can be added that capture and detect newly discovered threat agents. In addition to high multiplexing, thousands of microspheres from each region are used to detect each target in a single mix, providing for statistical accuracy. xMAP allows you to do more with less.
For the simultaneous detection of Botulinum toxins A, B, E, F, Ricin, and Staphylococcal Enterotoxin B.